IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS)

NCT03474263 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No enrollment

Conditions

Amyotrophic Lateral Sclerosis

Interventions

BIOLOGICAL: Biologic: IC14 (monoclonal antibody against human CD14)

Sponsor

Implicit Bioscience